Follow
Francesca Mallamaci
Francesca Mallamaci
Dirigente Medico UO di Nefrologia e Trapianto, Reggio Cal e CNR-IBIM, Reggio Cal.
Verified email at ibim.cnr.it
Title
Cited by
Cited by
Year
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
GP Rossi, G Bernini, C Caliumi, G Desideri, B Fabris, C Ferri, C Ganzaroli, ...
Journal of the American College of Cardiology 48 (11), 2293-2300, 2006
17222006
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
C Zoccali, SM Bode-Böger, F Mallamaci, FA Benedetto, G Tripepi, ...
The Lancet 358 (9299), 2113-2117, 2001
13272001
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease
C Zoccali, F Mallamaci, G Tripepi, FA Benedetto, S Cutrupi, S Parlongo, ...
Journal of the American Society of Nephrology 13 (1), 134-141, 2002
11332002
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease
C Zoccali, F Mallamaci, S Parlongo, S Cutrupi, FA Benedetto, G Tripepi, ...
Circulation 105 (11), 1354-1359, 2002
7402002
Vitamin D levels and patient outcome in chronic kidney disease
P Ravani, F Malberti, G Tripepi, P Pecchini, S Cutrupi, P Pizzini, ...
Kidney international 75 (1), 88-95, 2009
5842009
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
A Ortiz, A Covic, D Fliser, D Fouque, D Goldsmith, M Kanbay, F Mallamaci, ...
The lancet 383 (9931), 1831-1843, 2014
5042014
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
C Zoccali, FA Benedetto, R Maas, F Mallamaci, G Tripepi, LS Malatino, ...
Journal of the American Society of Nephrology 13 (2), 490-496, 2002
4912002
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach
P Ravani, G Tripepi, F Malberti, S Testa, F Mallamaci, C Zoccali
Journal of the American Society of Nephrology 16 (8), 2449-2455, 2005
4832005
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, G Giacone, ...
Kidney international 65 (4), 1492-1498, 2004
4552004
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients
C Zoccali, F Mallamaci, FA Benedetto, G Tripepi, S Parlongo, A Cataliotti, ...
Journal of the American Society of Nephrology 12 (7), 1508-1515, 2001
4262001
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, G Giacone, A Cataliotti, ...
Journal of the American Society of Nephrology 12 (12), 2768-2774, 2001
3902001
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
F Mallamaci, C Zoccali, G Tripepi, I Fermo, FA Benedetto, A Cataliotti, ...
Kidney international 61 (2), 609-614, 2002
3862002
Chronic fluid overload and mortality in ESRD
C Zoccali, U Moissl, C Chazot, F Mallamaci, G Tripepi, O Arkossy, ...
Journal of the American Society of Nephrology 28 (8), 2491-2497, 2017
3842017
The systemic nature of CKD
C Zoccali, R Vanholder, ZA Massy, A Ortiz, P Sarafidis, FW Dekker, ...
Nature Reviews Nephrology 13 (6), 344-358, 2017
3822017
Uric acid and endothelial dysfunction in essential hypertension
C Zoccali, R Maio, F Mallamaci, G Sesti, F Perticone
Journal of the American Society of Nephrology 17 (5), 1466-1471, 2006
3732006
Exercise in patients on dialysis: a multicenter, randomized clinical trial
F Manfredini, F Mallamaci, G D’Arrigo, R Baggetta, D Bolignano, C Torino, ...
Journal of the American Society of Nephrology 28 (4), 1259-1268, 2017
3722017
Inflammation is associated with carotid atherosclerosis in dialysis patients
C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, I Fermo, A Focà, ...
Journal of hypertension 18 (9), 1207-1213, 2000
3512000
Traditional and emerging cardiovascular risk factors in end-stage renal disease
C Zoccali, F Mallamaci, G Tripepi
Kidney International 63, S105-S110, 2003
3242003
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
C Zoccali, F Mallamaci, R Maas, FA Benedetto, G Tripepi, LS Malatino, ...
Kidney international 62 (1), 339-345, 2002
3202002
Long‐term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients
G Enia, F Mallamaci, FA Benedetto, V Panuccio, S Parlongo, S Cutrupi, ...
Nephrology Dialysis Transplantation 16 (7), 1459-1464, 2001
3162001
The system can't perform the operation now. Try again later.
Articles 1–20